BioLife Solutions Inc (BLFS)

Debt-to-capital ratio

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	4,997	17,561	23,793	6,353	655
Total stockholders’ equity	US$ in thousands	348,909	337,663	364,188	478,047	204,429
Debt-to-capital ratio		0.01	0.05	0.06	0.01	0.00

December 31, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $4,997K ÷ ($4,997K + $348,909K)
= 0.01

The debt-to-capital ratio of BioLife Solutions Inc has shown an overall increasing trend over the years, from 0.00 in December 31, 2020, to 0.01 in December 31, 2021, 0.06 in December 31, 2022, and 0.05 in December 31, 2023, before decreasing to 0.01 in December 31, 2024.

The low debt-to-capital ratio in 2020 indicates that the company was not heavily reliant on debt financing relative to its total capital structure. However, the substantial increase in the ratio in 2022 suggests that the company may have taken on more debt to finance its operations or growth initiatives.

The subsequent slight decrease in the ratio in 2023 and 2024 could be interpreted as the company effectively managing its debt levels or potentially reducing its debt obligations relative to its capital.

Overall, although the debt-to-capital ratio has fluctuated, it is essential to assess the trend in conjunction with other financial metrics to gain a comprehensive understanding of BioLife Solutions Inc's financial health and leverage position.